Drugs / Ezetemibe
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT07784621 | Oct 2026 → Feb 2027 expected | hypertensive disorder | Huons Co., Ltd. | Not yet recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05705804 | Jun 2023 → May 2027 expected | atherosclerotic cardiovascular disease, hyperlipidemia | Yonsei University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ezetemibe | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05705804 ↗ |